Weight loss

Five advancements in diabetes treatment to watch
Five advancements in diabetes treatment to watchThe healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.
Bariatric surgery costs vs. benefits: Plan coverage considerationsFrom a healthcare perspective, bariatric surgery is considered one of the most effective options for short-term and sustained weight loss. But does the investment pay off?
How providers, payers, employers should be fighting obesityBy addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term.
Successful provider, plan led weight loss programsHow one health system and one health plan are fighting the obesity epidemic
Four ways providers can use coaching to treat obese patientsLosing weight requires dramatic behavioral and lifestyle changes. Here’s how physicians can get patients on board.
New weight management pill available soonFDA recently approved the New Drug Application (NDA) for (lorcaserin HCl) CIV extended-release 20 mg tablets (Belviq XR, Eisai Inc. and Arena Pharmaceuticals), a once-a day dosing option for chronic weight management.
Bariatric surgery associated with improved psoriasis, psoriatic arthritis
Bariatric surgery associated with improved psoriasis, psoriatic arthritisStudy finds an association between excess weight loss post bariatric surgery and symptomatic improvement in cases of severe psoriasis. Learn more
Study: Weight loss key to manage asthma in obese adults
Study: Weight loss key to manage asthma in obese adultsIn obese adults with asthma, losing weight can help reduce asthma severity, according to the results of a Canadian study.
Study: FDA should warn consumers about chemical in weight loss supplements
Study: FDA should warn consumers about chemical in weight loss supplementsSeveral weight loss and fitness supplements contain the chemical BMPEA, a stimulant similar to amphetamine, according to a new study.
FDA should pull diabetes drug ads, group saysConsumer advocacy group Public Citizen said this week that the Food and Drug Administration (FDA) must stop direct-to-consumer advertisements that market several “dangerous” diabetes medications for weight loss or blood pressure reduction.